Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early oxycodone analgesia for radiation-induced oral mucositis pain in nasopharyngeal carcinoma
ChiCTR-TRC-13005175Phase 4Recruiting
- Sponsor
- Affiliated Cancer Hospital of Guangzhou Medical University
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oxycodone in stomatitis and nasopharyngeal carcinoma (NPC) (2 arms), sponsored by Affiliated Cancer Hospital of Guangzhou Medical University. Primary endpoints: Numeric rating scale and Body mass index. Started Jan 2015; status: recruiting.
02
Drugs
oxycodone
03
Conditions
stomatitisnasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ChiCTR-TRC-13005175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13005175.